Loading…
To amend the Internal Revenue Code of 1986 to allow additional expenses for purposes of determining the Hope Scholarship Credit, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2008 · fourth_quarter · Health Issues
Support legislation (H.R. 5269 and H.R. 1956) to provide for the approval of follow-on biologics (FOBs) that recognizes the complexity of large molecule product development and manufacturing, emphasizes patient safety, and contains adequate incentives for continued innovation. Address concerns with application of comparative effectiveness research as a blunt cost containment tool and the consequences to biomedical innovation and patient access. Oppose removal of medical device preemption provision from existing statute. Support legislation enacting a uniform federal pedigree standard for prescription drugs.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Support legislation (H.R. 5269 and H.R. 1956) to provide for the approval of follow-on biologics (FOBs) that recognizes the complexity of large molecule product development and manufacturing, emphasizes patient safety, and contains adequate incentives for continued innovation. Address concerns with application of comparative effectiveness research as a blunt cost containment tool and the consequences to biomedical innovation and patient access. Oppose removal of medical device preemption provision from existing statute. Support legislation enacting a uniform federal pedigree standard for prescription drugs.
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Support legislation (H.R. 5269 and H.R. 1956) to provide for the approval of follow-on biologics (FOBs) that recognizes the complexity of large molecule product development and manufacturing, emphasizes patient safety, and contains adequate incentives for continued innovation. Address concerns with application of comparative effectiveness research as a blunt cost containment tool and the consequences to biomedical innovation and patient access. Oppose removal of medical device preemption provision from existing statute. Support legislation enacting a uniform federal pedigree standard for prescription drugs.
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Taxation/Internal Revenue Code
H.R. 2458, "Universal Higher Education and Lifetime Learning Act," all titles; S. 1501, "Universal Higher Education and Lifetime Learning Act," all titles; H.R. 5269, allowing additional expenses for Hope Scholarship, all titles; general advocacy for changes to tax code in higher education financing.
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE